Bicycle Therapeutics plc (BCYC)
USD 15.32
(1.16%)
USD 15.32
(1.16%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -60.62 Million | -86.11 Million | -14.79 Million | -17.78 Million | -28.61 Million | -26.07 Million |
| Net Income | -180.66 Million | -112.71 Million | -66.81 Million | -51.01 Million | -30.6 Million | -21.84 Million |
| Depreciation & Amortization | 6.54 Million | 3.68 Million | 1.4 Million | 1.27 Million | 960 Thousand | 712 Thousand |
| Deferred income taxes | 3.3 Million | -4.97 Million | -1.66 Million | -673 Thousand | - | - |
| Stock-based compensation | 32.47 Million | 26.77 Million | 12.08 Million | 6.51 Million | 3.08 Million | 1.02 Million |
| Change in working capital | 76.66 Million | 672 Thousand | 38.06 Million | 25.35 Million | -7.42 Million | -6.63 Million |
| Other non-cash items | 1.04 Million | 442 Thousand | 2.13 Million | 751 Thousand | 5.38 Million | 665 Thousand |
| Investing Cash Flow | -2.92 Million | -18.98 Million | -2.03 Million | -1.2 Million | -1.55 Million | -1.18 Million |
| Investments in PPE | -2.92 Million | -18.98 Million | -2.03 Million | -1.2 Million | -1.55 Million | -1.18 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 250.02 Million | 6.69 Million | 320.72 Million | 62.84 Million | 58.44 Million | 25.43 Million |
| Debt repayment | - | - | -14.99 Million | -14.53 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 249.34 Million | 5.7 Million | 298.54 Million | 48.14 Million | 56.95 Million | 1000.00 |
| Other Financing Activities | 682 Thousand | 989 Thousand | 37.18 Million | 29.23 Million | 1.48 Million | 25.42 Million |
| Accounts receivables | 2.48 Million | -1.64 Million | 4.54 Million | -2.14 Million | 4.9 Million | -400 Thousand |
| Accounts payables | 8 Million | 2.56 Million | 1.19 Million | -663 Thousand | 220 Thousand | -169 Thousand |
| Inventory | -2.77 Million | - | -4.79 Million | 4.16 Million | -2.55 Million | -2.11 Million |
| Other working capital | 68.95 Million | -248 Thousand | 37.11 Million | 24 Million | -10 Million | -3.94 Million |
| Cash at beginning of period | 339.15 Million | 438.68 Million | 135.99 Million | 92.11 Million | 63.38 Million | 67.66 Million |
| Cash at end of period | 526.97 Million | 339.15 Million | 438.68 Million | 135.99 Million | 92.11 Million | 63.38 Million |
| Capital Expenditure | -2.92 Million | -18.98 Million | -2.03 Million | -1.2 Million | -1.55 Million | -1.18 Million |
| Effect of forex changes on cash | 1.34 Million | -1.12 Million | -1.21 Million | 19 Thousand | 465 Thousand | -2.44 Million |
| Net cash flow / Change in cash | 187.81 Million | -99.52 Million | 302.69 Million | 43.87 Million | 28.73 Million | -4.28 Million |
| Free Cash Flow | -63.55 Million | -105.09 Million | -16.82 Million | -18.98 Million | -30.16 Million | -27.26 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -50.77 Million | -39.85 Million | -26.54 Million | -180.66 Million | -49.09 Million | -49.89 Million |
| Depreciation & Amortization | 2.17 Million | 1.64 Million | 1.65 Million | 6.54 Million | 1.65 Million | 1.69 Million |
| Deferred income taxes | -3.31 Million | -110.71 Thousand | -766.56 Thousand | 3.3 Million | -282 Thousand | 7.27 Million |
| Stock-based compensation | 9.2 Million | 9.26 Million | 9.28 Million | 32.47 Million | 7.81 Million | 7.43 Million |
| Change in working capital | 70.32 Million | -15.76 Million | -54.55 Million | 76.66 Million | -8.12 Million | 32.39 Million |
| Other non-cash items | -67.4 Million | 20.66 Million | 33.87 Million | 1.04 Million | 755 Thousand | 91 Thousand |
| Investing Cash Flow | -434.86 Thousand | -420.14 Thousand | -11.99 Thousand | -2.92 Million | -51 Thousand | -502 Thousand |
| Investments in PPE | -434.86 Thousand | -420.14 Thousand | -11.99 Thousand | -2.92 Million | -51 Thousand | -502 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -32.1 Million | 549.77 Million | 1.86 Million | 250.02 Million | 386 Thousand | 234.63 Million |
| Debt repayment | -32 Million | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -551.64 Million | 549.77 Million | 1.86 Million | 249.34 Million | 252.65 Thousand | 235.63 Million |
| Other Financing Activities | 519.54 Million | 549.6 Million | 1.87 Million | 682 Thousand | 133.34 Thousand | -1 Million |
| Accounts receivables | 22.81 Million | -7.55 Million | -15.25 Million | 2.48 Million | -5.9 Million | -49.87 Million |
| Accounts payables | -1.23 Million | -436.37 Thousand | -5.91 Million | 8 Million | 4.16 Million | 3.81 Million |
| Inventory | - | - | - | -2.77 Million | 5.9 Million | -11.23 Million |
| Other working capital | 41.15 Million | -7.77 Million | -33.37 Million | 68.95 Million | -12.29 Million | 89.69 Million |
| Cash at beginning of period | 961.36 Million | 456.99 Million | 526.42 Million | 339.15 Million | 572.63 Million | 340.43 Million |
| Cash at end of period | 891.4 Million | 961.36 Million | 456.99 Million | 526.97 Million | 526.97 Million | 572.63 Million |
| Capital Expenditure | -434.86 Thousand | -420.14 Thousand | -11.99 Thousand | -2.92 Million | -51 Thousand | -502 Thousand |
| Effect of forex changes on cash | 1.69 Million | -192 Thousand | -416 Thousand | 1.34 Million | 1.28 Million | -903 Thousand |
| Net cash flow / Change in cash | -69.95 Million | 504.36 Million | -69.42 Million | 187.81 Million | -45.66 Million | 232.2 Million |
| Free Cash Flow | -40.23 Million | -45.12 Million | -70.84 Million | -63.55 Million | -47.33 Million | -1.52 Million |
060980
LSPKF
LIS
REXR-PB
NESCO
013570